Education Programs for Chronic Kidney Disease
(ExPAND Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how to best assist older patients with chronic kidney disease in making informed treatment decisions. It compares two approaches: one educates patients about all treatment options, including alternatives to dialysis, while the other adds extra support such as symptom management and care planning. The goal is to determine which method better aids patients in choosing the right treatment and reduces decision-related stress. Patients with chronic kidney disease experiencing significant kidney function decline who have not yet started dialysis might be suitable for this trial. As an unphased trial, this study provides patients the opportunity to contribute to research that could enhance decision-making and reduce stress for others facing similar health challenges.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that these educational approaches are safe for patients with chronic kidney disease?
Research shows that education programs for chronic kidney disease (CKD) primarily help patients understand their choices. These programs aim to enhance decision-making and condition management, which is crucial for those with CKD. Specific safety information for these education programs is not available, likely because they focus on teaching and decision support rather than medical treatments.
The Educate and Engage Plus Kidney Supportive Care Program, which provides extra support for those choosing different treatment plans (such as palliative care), also lacks detailed safety information. This program's main goal is to offer additional help through care organization, symptom management, and emotional support.
Since both approaches in the trial emphasize education and support instead of medical treatments, they are likely very safe. They aim to provide patients with knowledge and support, making them low-risk in terms of physical safety.12345Why are researchers excited about this trial?
Researchers are excited about these education programs for chronic kidney disease because they offer a fresh approach to patient care. Unlike traditional treatments that primarily focus on medication and dialysis, these programs emphasize patient education and engagement, empowering patients to make informed decisions about their health. The Educate and Engage Plus Kidney Supportive Care Program goes a step further by integrating supportive care, aiming to improve overall patient wellbeing and possibly slow disease progression. This holistic approach can potentially enhance quality of life, which is why it stands out from conventional methods.
What evidence suggests that this trial's approaches could be effective for chronic kidney disease?
Research has shown that when patients with chronic kidney disease (CKD) learn about their treatment options, they can make better decisions. Studies have found that shared decision-making (SDM) programs, where patients actively choose their treatments, can reduce uncertainty and increase satisfaction. In this trial, participants will be assigned to one of two approaches. The Educate and Engage approach provides clear information and uses proven tools to help patients make decisions, encouraging them to consider different treatment plans.
The Educate and Engage Plus Kidney Supportive Care Program, on the other hand, offers additional support for those who choose alternative treatment plans. This includes organizing care and managing symptoms, which can improve quality of life. Early results suggest that patients who receive this extra support feel they receive better care. Overall, these strategies aim to empower patients in their treatment journey, potentially leading to better outcomes and satisfaction.16789Are You a Good Fit for This Trial?
This trial is for older patients with kidney failure who are exploring treatment options. Participants should be willing to engage in educational programs about kidney disease, use decision aids, and participate in shared decision-making processes.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Educate and Engage
Nephrology practices implement a bundle to encourage participation in a kidney disease education program, use of decision aids, and engagement in shared decision-making.
Educate and Engage Plus Kidney Supportive Care Program
Nephrology practices add a primary palliative care program to support patients choosing alternative treatment plans with care coordination, symptom management, and psychosocial support.
Follow-up
Participants are monitored for safety and effectiveness after treatment, including chart reviews and surveys.
What Are the Treatments Tested in This Trial?
Interventions
- Educate and Engage
- Educate and Engage Plus Kidney Supportive Care Program
Educate and Engage is already approved in United States for the following indications:
- Patient Education for Kidney Failure Treatment Options
Find a Clinic Near You
Who Is Running the Clinical Trial?
George Washington University
Lead Sponsor
Patient-Centered Outcomes Research Institute
Collaborator
West Virginia University Research Corporation
Collaborator
University of Bristol
Collaborator